SCHEDULE 13G/A: Intracoastal Capital and Affiliates Report 6.3% Beneficial Ownership in Microbot Medical Inc.

Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, has filed an amended Schedule 13G reporting a 6.3% beneficial ownership stake in Microbot Medical Inc. as of March 31, 2025.

Summary

• Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC (collectively, the "Reporting Persons") have filed an Amendment No. 1 to Schedule 13G regarding their beneficial ownership in Microbot Medical Inc.
• As of March 31, 2025, the Reporting Persons collectively beneficially owned 2,349,488 shares of Microbot Medical Inc. common stock.
• This beneficial ownership represents approximately 6.3% of the company's common stock, calculated based on 34,744,476 shares outstanding as of March 25, 2025, plus the 2,349,488 shares issuable upon exercise of Intracoastal Warrant 1.
• The reported beneficial ownership excludes shares from four other warrants held by Intracoastal (Intracoastal Warrant 2, 3, 4, and 5) due to various blocker provisions and exercisability conditions.
• Intracoastal Warrant 2 (2,816,902 shares) is not exercisable until the later of the amendment to the Issuer's articles of incorporation to increase authorized shares and stockholder approval, and contains a 9.99% beneficial ownership blocker.
• Intracoastal Warrants 3 (221,062 shares), 4 (783,336 shares), and 5 (2,514,286 shares) each contain a 4.99% beneficial ownership blocker provision.
• Without these blocker provisions, the Reporting Persons would have been deemed to beneficially own 8,685,074 shares of Common Stock.

Sentiment

Score: 5

Explanation: The document is a factual, compliance-driven filing (Schedule 13G/A) reporting beneficial ownership. It does not contain subjective language or express positive or negative sentiment regarding the company's performance or outlook.

Future Outlook

The document does not provide any forward-looking statements or guidance from Microbot Medical Inc. or the Reporting Persons regarding the company's future operations or financial performance.

Industry Context

This filing is a routine disclosure of a significant ownership stake by an investment group in a publicly traded company, as required by SEC regulations. It does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant ownership stake held by an investment group, which can influence perceptions of control and potential future actions by the group.

Key Dates

Keywords

Microbot Medical Inc., beneficial ownership, Schedule 13G, common stock, Intracoastal Capital LLC, Mitchell P. Kopin, Daniel B. Asher, warrants, SEC filing